The Quantellect read.As of Nov 19, 2026, 5 active firms cover Cellectis SA: 2 rate it Buy or better, 2 sit at Neutral, and 1 rate it Sell or worse, a neutral consensus. The target range is very wide, $1.30 to $9.00 (about 6.9x), which points to deep disagreement over how to value the company rather than near-term timing. The average target of $5.86 sits 475% above the current $1.02. Sentiment has cooled somewhat, with Sell ratings rising from 0 to 1 over recent months. On the fundamentals, the Street sees consensus EPS building from about $-0.19 next quarter toward $-0.55 the year after.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS5 active firms
Neutral
Strong Buy00%
Buy240%
Neutral240%
Sell120%
Strong Sell00%
Based on 5 active firms as of Nov 19, 2026 (365-day activity window).
12-MONTH PRICE TARGET
$5.86
+474.5% upside
Average target across 5 active firms as of Nov 19, 2026 vs $1.02 current
Highest Target$9.00
Average Target$5.86
Lowest Target$1.30
Detailed analyst forecasts for CLLS
Showing 1–5 of 5 named analysts shown · 5 active firms in the rating projection
As of Nov 19, 2026, 2 of 5 active firms rate CLLS a Buy (2 Neutral, 1 Sell). Historical months are month-end active-firm counts; the current month uses its actual as-of date.
CLLS EPS & revenue forecast
EPS · NEXT QUARTER
$-0.19
Range $-0.19 – $-0.19 · 1 analysts
Next period, 1 analysts expect Cellectis SA to earn $-0.19 a share (range $-0.19 – $-0.19), versus — a year earlier. Full-year consensus is $-1.25, growing to $-0.55 the year after.
REVENUE · NEXT QUARTER
$22.7M
Range $6.8M – $53.7M · 1 analysts · +254% YoY
Revenue is expected to reach $22.7M (range $6.8M – $53.7M), +253.9% year-over-year. Full-year consensus is $29.2M, rising to $36.1M next year.
Top analysts covering Cellectis SA
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on CLLS.
#1
Gena Wang
Barclays · Rank #410
Buy
$8.00+684.3% to target
Overall win rate
32%
+ Follow
#2
LS
Lukas Shumway
Barclays
Sell
$1.30+27.5% to target
Coverage
—
+ Follow
#3
Yanan Zhu
Wells Fargo
Neutral
$3.00+194.1% to target
Coverage
—
+ Follow
#4
ST
Silvan Turkcan
Citizens
Neutral
No targeton CLLS
Coverage
—
+ Follow
#5
JA
Jack Allen
Baird
Buy
$8.00+684.3% to target
Coverage
—
+ Follow
CLLS stock forecast FAQ
What is CLLS's average 12-month price target?+
The 5 active firms with a live target average $5.86 for Cellectis SA over the next 12 months, ranging from a $9.00 high to a $1.30 low, as of Nov 19, 2026.
Is CLLS stock a Buy, Sell or Neutral right now?+
The current consensus is Neutral. Of the 5 active firms as of Nov 19, 2026, 2 rate it Buy or Strong Buy, 2 rate it Neutral, and 1 rate it Sell or Strong Sell.
What are the highest and lowest price targets for CLLS?+
The Street-high target is $9.00 (Clear Street), and the Street-low is $1.30 (Barclays). The average of all 5 active-firm targets is $5.86.
How many active Wall Street firms cover CLLS?+
5 active firms have a recognized rating on Cellectis SA as of Nov 19, 2026, and 5 active firms carry a live 12-month price target.
Who is the most accurate analyst covering CLLS?+
Among analysts who currently cover CLLS, Gena Wang of Barclays has the strongest overall Quantellect track record (Rank #410). Their current call is Buy with a $8.00 target.
What is Cellectis SA's projected EPS for next quarter?+
The consensus estimate is $-0.19 per share (range $-0.19 – $-0.19) across 1 analysts. Full-year EPS is projected at $-1.25, rising to $-0.55 the following year.
How much revenue is Cellectis SA expected to report next quarter?+
Consensus revenue is $22.7M (range $6.8M – $53.7M). Full-year revenue is projected at $29.2M, growing to $36.1M next year.
Have analysts been upgrading or downgrading CLLS lately?+
As of Nov 19, 2026, 2 of 5 active firms rate CLLS a Buy (2 Neutral, 1 Sell). Historical months are month-end active-firm counts; the current month uses its actual as-of date.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their CLLS calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.